Home › Stocks › IPSC › All Fund Holders
IPSC — CENTURY THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 36 · Reported value held: $92.30M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 8.09M | $19.82M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 5.52M | $13.53M | 0.02% | Add |
| Point72 Asset Management history | Q2 2026 | 4.98M | $12.20M | 0.01% | Reduce |
| Millennium Management history | Q2 2026 | 4.19M | $10.28M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 2.98M | $7.30M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 2.70M | $6.61M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 1.59M | $3.91M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 1.26M | $3.08M | 0.00% | Add |
| Casdin Capital history | Q2 2026 | 1.23M | $3.01M | 0.15% | Hold |
| Hillhouse Capital (HHLR Advisors) history | Q4 2022 | 496.62K | $2.55M | 0.05% | Reduce |
| Vanguard Group history | Q4 2025 | 2.10M | $2.09M | 0.00% | Hold |
| Marshall Wace history | Q2 2026 | 537.99K | $1.32M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 381.42K | $934.48K | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 378.87K | $928.22K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 351.77K | $861.84K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 299.01K | $732.58K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 232.41K | $569.40K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 158.89K | $389.29K | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 150.43K | $368.56K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 148.91K | $364.84K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 120.23K | $294.57K | 0.00% | New |
| D. E. Shaw & Co history | Q1 2022 | 22.44K | $282.00K | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 81.90K | $200.66K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 57.00K | $139.65K | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 51.21K | $123.41K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 43.96K | $107.70K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 38.45K | $94.21K | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 34.60K | $84.78K | 0.00% | New |
| Prudential Financial history | Q2 2026 | 18.59K | $45.56K | 0.00% | Reduce |
| Franklin Resources history | Q2 2023 | 12.52K | $39.55K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 8.99K | $22.04K | 0.00% | Add |
| AQR Capital Management history | Q3 2025 | 10.66K | $5.31K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2025 | 6.27K | $3.51K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 101.16K | $248 | 0.00% | New |
| Royce & Associates history | Q4 2022 | 11.43K | $59 | 0.00% | New |
| Lazard Asset Management history | Q2 2025 | 62.95K | $35 | 0.00% | New |